London, Jan.26 (ANI): Doctors were preparing to treat Lockerbie bomber Adbelbaset Ali Mohmed al-Megrahi with drugs that could have extended his life by at least 19 months when he was released from a Scottish prison, according to a new investigation into the controversy.
A Vanity Fair magazine investigation claims al-Megrahi was going to start chemotherapy to treat prostate cancer in a Scottish prison when he was released.
Dr. Karol Sikora, an oncologist, told the magazine that two drugs could have been considered, one of which would have extended the Libyan's life by up to 19 months and the other by "many months" more than that.
However, according to The Telegraph, al-Megrahi was released shortly after on compassionate grounds on the basis he had less than three months to live.
He later started chemotherapy in Libya and is still alive more than 17 months later.
The magazine concludes the decision was a "fix" and linked to Britain's commercial interests. (ANI)